Seeing Is Believing
Currently out of the existing stock ratings of Paul Choi, 35 are a SELL (19.55%), 68 are a HOLD (37.99%), 76 are a BUY (42.46%).
Analyst Paul Choi works with a stock forecast success ratio of 60.82% fulfilled within 129.5 days on average. Previously, Paul Choi worked at GOLDMAN SACHS.
Paul Choi’s has documented 364 price targets and ratings displayed on 38 stocks. The coverage was on Healthcare, Pharmaceuticals sectors.
Most recent stock forecast was given on CYTK, Cytokinetics at 28-Dec-2023.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for VIR (VIR BIOTECHNOLOGY) at 3/1/2021. The price target of $61 was fulfilled within 1 day with a profit of $5.73 (8.59%) receiving and performance score of 85.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1
$-0.28 (-21.88%)
1.5
2 months 12 days ago
5/6 (83.33%)
$-0.02 (-1.96%)
301
Buy
3
$1.72 (134.38%)
2 months 12 days ago
0/2 (0%)
$1.98 (194.12%)
Buy
3 months 11 days ago
1/1 (100%)
$32.69 (83.16%)
358
Buy
9
$7.72 (603.13%)
10 months 18 days ago
2/4 (50%)
$4.84 (116.35%)
178
Buy
7
$5.72 (446.88%)
7
1 years 22 days ago
1/3 (33.33%)
$0.45 (6.87%)
57
Which stock is Paul Choi is most bullish on?
Which stock is Paul Choi is most reserved on?
What Year was the first public recommendation made by Paul Choi?